Brookwood Investment Group’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
6,535
+16
+0.2% +$2.37K 0.14% 156
2026
Q1
$607K Sell
6,519
-1,881
-22% -$167K 0.07% 248
2025
Q4
$675K Hold
8,400
– – 0.08% 229
2025
Q3
$820K Hold
8,400
– – 0.11% 180
2025
Q2
$585K Hold
8,400
– – 0.09% 210
2025
Q1
$417K Buy
+8,400
New +$531K 0.07% 249

Other funds holding ACLS

Brookwood Investment Group's ACLS Position: Q2 2026 in Review

Brookwood Investment Group increased its Axcelis (ACLS) stake by 0.25% in Q2 2026, buying an estimated $2.37K and bringing the position to 6,535 shares worth $1.24M. The position accounts for 0.14% of the portfolio, ranked #156.

Brookwood Investment Group first reported a position in ACLS in Q1 2025 and has held it in 6 quarters since. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Brookwood Investment Group held 6,535 shares of Axcelis worth $1.24M as of Q2 2026.
  • Brookwood Investment Group bought 16 Axcelis shares in Q2 2026, an estimated $2.37K.
  • Axcelis made up 0.14% of Brookwood Investment Group's portfolio in Q2 2026, its #156 holding.
  • Brookwood Investment Group first reported a position in Axcelis in Q1 2025 and has held it in 6 quarters since.
  • 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Brookwood Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.